In The News Posted January 16, 2019 Share Posted January 16, 2019 CAMBRIDGE, Mass., Jan. 16, 2019 /PRNewswire/ -- BlueRock Therapeutics, LP, an engineered cell therapy company leveraging its novel Cell+Gene platform to develop regenerative medicines for intractable diseases, today announced the establishment of partnerships with Bruce Blazar, M.D.,... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.